Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Adenocarcinoma of the Breast”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT02282345
What this trial is testing

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Who this might be right for
Breast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05900986
What this trial is testing

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Who this might be right for
Breast CancerDCISInvasive Duct Carcinoma of Breast
Integro Theranostics 100
Not applicableLooking for participantsNCT07122713
What this trial is testing

Definitive Radiation Therapy for Inoperable Breast Cancer

Who this might be right for
Breast CancerBreast Adenocarcinoma
Alexander Stessin 30
Not applicableStudy completedNCT00058058
What this trial is testing

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Who this might be right for
Breast CancerContralateral Breast Cancer
American College of Radiology Imaging Network 1,007
Not applicableStudy completedNCT01815476
What this trial is testing

The Prone Breast Radiation Therapy Trial

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Toronto Sunnybrook Regional Cancer Centre 378
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Not applicableStudy completedNCT04022772
What this trial is testing

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituInvasive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 287
Post-approval studies (Phase 4)Looking for participantsNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 68
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableEnded earlyNCT01075607
What this trial is testing

Lymph Fluid and Blood Collection for Identification of Novel Biomarkers

Who this might be right for
Adenocarcinoma of the Breast
Indiana University 50
Large-scale testing (Phase 3)Study completedNCT01426880
What this trial is testing

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 595
Testing effectiveness (Phase 2)UnknownNCT01292408
What this trial is testing

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Who this might be right for
Breast Cancer
Radboud University Medical Center 20
Large-scale testing (Phase 3)Temporarily pausedNCT02037529
What this trial is testing

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2/Neu NegativeInvasive Breast Carcinoma+2 more
Academic and Community Cancer Research United 201
Not applicableStudy completedNCT04245150
What this trial is testing

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

Who this might be right for
DCISInvasive Breast Cancer
Case Comprehensive Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Early research (Phase 1)Active Not RecruitingNCT02453620
What this trial is testing

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
National Cancer Institute (NCI) 57
Load More Results